• About Us
    • Contact Us
    • Login
    • ObGFirst
  • COVID-19
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • GrandRounds
  • My Bookshelf
  • Now@ObG
  • Media
About Us Contact Us Login ObGFirst
  • COVID-19
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • GrandRounds
  • My Bookshelf
  • Now@ObG
  • Media
Grand Rounds

Does Elective Induction at 39 Weeks Impact Early Childhood Educational Outcomes?

image_pdfFavoriteLoadingFavorite

BACKGROUND AND PURPOSE:

  • Yisma et al. (Ultrasound in Obstetrics & Gynecology, 2021) examined the effect of elective induction of labor at 39 weeks on children’s educational outcomes vs expectant management

METHODS:

  • Retrospective cohort study
    • South Australia between 1999 to 2008
  • Population
    • All infants born at 39 to 42 weeks | Vertex presentation
    • Children who had school assessment data from the National Assessment Program—Literacy and Numeracy (NAPLAN) test in school year 3 (approximately 8 years of age)
    • Exclusion: Births with medical indications for delivery <39 weeks
  • Exposures
    • Elective induction of labor >39 weeks
    • Expectant management: Spontaneous labor, elective induction of labor or medically indicated induction and cesarean deliveries from 40 to 42 weeks
  • Study design
    • Propensity scoring was used to determine treatment effects, with adjustment for potential confounders
  • Primary outcome
    • Children’s educational outcome as measured using NAPLAN
      • Includes five learning domains: Reading | Writing | Spelling | Grammar | Numeracy
      • Each domain was categorized against the national minimum standard (NMS)

RESULTS:

  • 31,120 children born during study period with at least one year-3 NAPLAN domain
    • Elective induction: 1,353 children
    • Expectant management: 29,767 children
  • Average treatment effects (mean differences) of elective induction at 39 weeks vs expectant management (proportion of children scoring at/below the NMS)
    • Reading: 0.01 (95% CI, -0.02 to 0.03)
    • Writing: 0.02 (95% CI, 0.00 to 0.04)
    • Spelling: 0.01 (95% CI, -0.01 to 0.04)
    • Grammar: 0.02 (95% CI, -0.01 to 0.04)
    • Numeracy: 0.03 (95% CI, 0.00 to 0.05)

CONCLUSION:

  • Elective induction at 39 weeks vs expectant management had no significant effect on children’s educational performance at 8 years of age
  • The authors state

Despite the large amount of evidence regarding the short-term outcome of elective induction of labor at 39 weeks, there is limited evidence regarding the longer-term neurodevelopmental effects

These findings provide the first contribution on the effect of elective induction of labor at 39 weeks to the ongoing scientific discourse on longer-term neurodevelopmental outcomes

Learn More – Primary Sources:

Elective labor induction vs expectant management of pregnant women at term and children’s educational outcomes at 8 years of age

Want to stay on top of key guidelines and research papers?

ObGFirst® – Try It Free! »

image_pdfFavoriteLoadingFavorite
< Previous
All Grand Rounds Posts
Next >

Related ObG Topics:

Cesarean Delivery and Risk of Neurodevelopmental Disorders: Is There a Real Link?
HYPITAT-II Childhood Neurodevelopmental Outcomes: Delivery or Expectant Management for Non-Severe Late Preterm Hypertension?
Does Hydrocortisone Treatment in Preterm Infants Impact Neurodevelopment?

Sections

  • COVID-19
  • Alerts
  • OB
  • GYN
    • GYN
    • Sexual Health
  • 2T US Atlas
  • The Genome
  • Primary Care
  • Your Practice
  • Grand Rounds
  • My Bookshelf
  • Now@ObG
  • Media

Are you an
ObG Insider?

Get specially curated clinical summaries delivered to your inbox every week for free

  • Site Map/
  • © ObG Project/
  • Terms and Conditions/
  • Privacy/
  • Contact Us/
© ObG Project
SSL Certificate


  • Already an ObGFirst Member?
    Welcome back

    Log In

    Want to sign up?
    Get guideline notifications
    CME Included

    Sign Up

Download Your ObG App
HERE!

Sign In

Lost your password?

Sign Up for ObGFirst and Stay Ahead

  • - Professional guideline notifications
  • - Daily summary of a clinically relevant
    research paper
  • - Includes 1 hour of CME every month

ObGFirst Free Trial

Already a Member of ObGFirst®?

Please log in to ObGFirst to access the 2T US Atlas

Password Trouble?

Not an ObGFirst® Member Yet?

  • - Access 2T US Atlas
  • - Guideline notifications
  • - Daily research paper summaries
  • - And lots more!
ObGFirst Free Trial

Media - Internet

Computer System Requirements

OBG Project CME requires a modern web browser (Internet Explorer 10+, Mozilla Firefox, Apple Safari, Google Chrome, Microsoft Edge). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, or Real Networks Real One Player.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information
presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Jointly provided by

NOT ENOUGH CME HOURS

It appears you don't have enough CME Hours to take this Post-Test. Feel free to buy additional CME hours or upgrade your current CME subscription plan

Subscribe

JOIN OBGFIRST AND GET CME/CE CREDITS

One of the benefits of an ObGFirst subscription is the ability to earn CME/CE credits from the ObG entries you read. Tap the button to learn more about ObGFirst

Learn More
Leaving ObG Website

You are now leaving the ObG website and on your way to PRIORITY at UCSF, an independent website. Therefore, we are not responsible for the content or availability of this site